MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

Model Number 0500316E

Device Problem Fluid/Blood Leak (1250)

Patient Problem No Clinical Signs, Symptoms or Conditions (4582)

Event Date 05/13/2022

Event Type  malfunction  

Manufacturer Narrative

Plant investigation: the plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.

Event Description

A user facility reported that an internal dialyzer blood leak occurred two minutes after initiation of a patient¿s hemodialysis (hd) treatment.The blood leak alarm occurred when blood hit the venous chamber.No visible blood was noted.The machine, a fresenius 2008t, alarmed appropriately with a blood leak alert.Fresenius bloodlines were being utilized for the treatment.Blood test strips were used and tested positive for the presence of blood.No damage was identified on the dialyzer prior to use.The patient's blood was not returned.Immediately following the event, the patient was re-setup with new supplies on a different machine where they were able to complete treatment.The patient¿s estimated blood loss (ebl) was 200 ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The dialyzer was available to be returned for a manufacturer evaluation.

Event Description

A user facility reported that an internal dialyzer blood leak occurred two minutes after initiation of a patient¿s hemodialysis (hd) treatment.The blood leak alarm occurred when blood hit the venous chamber.No visible blood was noted.The machine, a fresenius 2008t, alarmed appropriately with a blood leak alert.Fresenius bloodlines were being utilized for the treatment.Blood test strips were used and tested positive for the presence of blood.No damage was identified on the dialyzer prior to use.The patient's blood was not returned.Immediately following the event, the patient was re-setup with new supplies on a different machine where they were able to complete treatment.The patient¿s estimated blood loss (ebl) was 200 ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The dialyzer was available to be returned for a manufacturer evaluation.

Manufacturer Narrative

Additional information: g2.

Event Description

A user facility reported that an internal dialyzer blood leak occurred two minutes after initiation of a patient¿s hemodialysis (hd) treatment.The blood leak alarm occurred when blood hit the venous chamber.No visible blood was noted.The machine, a fresenius 2008t, alarmed appropriately with a blood leak alert.Fresenius bloodlines were being utilized for the treatment.Blood test strips were used and tested positive for the presence of blood.No damage was identified on the dialyzer prior to use.The patient's blood was not returned.Immediately following the event, the patient was re-setup with new supplies on a different machine where they were able to complete treatment.The patient¿s estimated blood loss (ebl) was 200 ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The dialyzer was available to be returned for a manufacturer evaluation.

Manufacturer Narrative

Correction: h2 in prior submission selected as "additional information" instead of "correction".

Event Description

A user facility reported that an internal dialyzer blood leak occurred two minutes after initiation of a patient¿s hemodialysis (hd) treatment.The blood leak alarm occurred when blood hit the venous chamber.No visible blood was noted.The machine, a fresenius 2008t, alarmed appropriately with a blood leak alert.Fresenius bloodlines were being utilized for the treatment.Blood test strips were used and tested positive for the presence of blood.No damage was identified on the dialyzer prior to use.The patient's blood was not returned.Immediately following the event, the patient was re-setup with new supplies on a different machine where they were able to complete treatment.The patient¿s estimated blood loss (ebl) was 200 ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The dialyzer was available to be returned for a manufacturer evaluation.

Manufacturer Narrative

Plant investigation: the reported complaint was not confirmed as the complaint device was not returned to date for manufacturer evaluation.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There was one approved temporary deviation notice (dn) reported on the lot which was unrelated to the complaint event.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.A definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual device.Therefore, the complaint is not confirmed.The reported lot number passed pyrogen testing, was within sterilization dosage parameters and passed all release criteria.There is no recall associated with this complaint.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program, in order to assess and improve our products and processes.Capas 2018-0171 (vision systems) and 2018-0161 (blood leak reduction) are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.

• Brand Name: OPTIFLUX 160NRE DIALYZER FINISHED ASSY.
• Type of Device: DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
• Manufacturer (Section D): OGDEN MANUFACTURING PLANT; director, site quality; 475 west 13th street; ogden UT 84404
• Manufacturer (Section G): OGDEN MANUFACTURING PLANT; director, site quality; 475 west 13th street; ogden UT 84404
• Manufacturer Contact: jessica trujillo ; 920 winter st; waltham, MA 02451 ; 6174175172
• MDR Report Key: 14436447
• MDR Text Key: 292217810
• Report Number: 0001713747-2022-00164
• Device Sequence Number: 1
• Product Code: KDI
• UDI-Device Identifier: 00840861100149
• UDI-Public: 00840861100149
• Combination Product (y/n): N
• Reporter Country Code: US
• PMA/PMN Number: K162488
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Health Professional,User Facility
• Reporter Occupation: Administrator/Supervisor
• Type of Report: Initial,Followup,Followup,Followup
• Report Date: 06/17/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Expiration Date: 05/31/2023
• Device Model Number: 0500316E
• Device Catalogue Number: 0500316E
• Device Lot Number: 21PU01004
• Was Device Available for Evaluation?: No
• Device Age: MO
• Initial Date Manufacturer Received: 05/16/2022
• Initial Date FDA Received: 05/19/2022
• Supplement Dates Manufacturer Received: 06/15/2022; 06/15/2022; 06/16/2022
• Supplement Dates FDA Received: 06/15/2022; 06/16/2022; 06/17/2022
• Was Device Evaluated by Manufacturer?: Device Not Returned to Manufacturer
• Date Device Manufactured: 11/04/2021
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Treatment: FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES
• Patient Age: 68 YR
• Patient Sex: Male
• Patient Weight: 55 KG